182 related articles for article (PubMed ID: 36382661)
1. MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review).
Liang X; Wu Q; Wang Y; Li S
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382661
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of microrna for lung cancer.
Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
[TBL] [Abstract][Full Text] [Related]
3. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.
Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
[TBL] [Abstract][Full Text] [Related]
6. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer.
Jiang YF; Wei SN; Geng N; Qin WW; He X; Wang XH; Qi YP; Song S; Wang P
Sci Rep; 2022 Oct; 12(1):17201. PubMed ID: 36229645
[TBL] [Abstract][Full Text] [Related]
10. Utilizing MiSeq Sequencing to Detect Circulating microRNAs in Plasma for Improved Lung Cancer Diagnosis.
Geng X; Tsou JH; Stass SA; Jiang F
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373422
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.
Cui R; Meng W; Sun HL; Kim T; Ye Z; Fassan M; Jeon YJ; Li B; Vicentini C; Peng Y; Lee TJ; Luo Z; Liu L; Xu D; Tili E; Jin V; Middleton J; Chakravarti A; Lautenschlaeger T; Croce CM
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4288-97. PubMed ID: 26187928
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
14. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
16. Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer.
Samson JS; Parvathi VD
Med Oncol; 2023 Nov; 40(12):345. PubMed ID: 37922117
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.
Zhang J; Li D; Zhang Y; Ding Z; Zheng Y; Chen S; Wan Y
Oncol Rep; 2020 Jan; 43(1):99-112. PubMed ID: 31746439
[TBL] [Abstract][Full Text] [Related]
18. Expression of microRNAs-106b in nonsmall cell lung cancer.
Li Y; Tian J; Guo ZJ; Zhang ZB; Xiao CY; Wang XC
J Cancer Res Ther; 2018 Jun; 14(Supplement):S295-S298. PubMed ID: 29970679
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
20. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
